ArticlePloS one2022

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.

Chotaro Onaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.